If you would like to receive Perspective - our monthly newsletter – which brings you all of our latest news and views as well as interviews and opinion pieces then please follow the link below...
Pharmaceutical supply chains 'must be more robust'
The government has urged pharmaceutical companies to ensure their supply chain operations are more "robust" and equipped to withstand unforeseen events.
In new guidance published by the Department of Health, drug manufacturers were advised to make sure "contingency arrangements" are in place to maintain supply where stock is exhausted.
The department's intervention follows the extreme weather conditions seen in the UK before Christmas, when pharmaceutical supply chains across the country suffered widespread disruption.
Its advice also recommended that companies in the sector undertake "customer audits or surveys to assess the performance of supply arrangements" when appropriate.
The Royal Pharmaceutical Society (RPS) called for improvements in the drug supply chain earlier this month.
Alex MacKinnon, director for RPS Scotland, described the current state of operations as "brittle" and claimed the supply chain "cannot flex with increases in demand or logistical challenges".
A survey conducted by the society found that 97 per cent of respondents believe there are structural weaknesses in the medicine supply chain.
Odgers Interim are UK leaders in Interim Management solutions for the Commercial Sector. We have offices in London, Birmingham, Leeds, Manchester, Glasgow, Aberdeen and Cardiff as well as over 50 offices globally. We are the only Interim Management providers who are part of a top tier international executive search firm. We work closely with our executive search colleagues to find candidates who can offer short term solutions with long term benefits. www.odgersinterim.com